2.6
グレーブス病は自己免疫疾患で、甲状腺刺激免疫グロブリン(TSI)がTSH受容体を活性化し、甲状腺ホルモン(T3およびT4)の過剰な合成と放出を引き起こし、甲状腺機能亢進症を引き起こします。
甲状腺機能亢進症のあらゆる原因の中で、グレーブズ病が最も一般的で、どの年齢でも発症する可能性がありますが、女性の…
グレーブドウ病は、免疫系が耐性を維持できなくなり、形質細胞が甲状腺刺激性免疫グロブリン(TSI)を産生・放出できるようになったときに始まります。
これらの抗体は甲状腺濾胞細胞の甲状腺刺激ホルモン受容体(TSH-R)に結合し、甲状腺刺激ホルモン(TSH)の作用を模倣します。
抗体によって受容体が継続的に過剰刺激されると、甲状腺は正常な調節制御なしに大量のチロキシン(T4)とトリヨードチロニン(T3)を産生・放出します。
顕微鏡的には、濾胞細胞が高く密集し、血管が増加し、コロイド貯蔵が急速に減少し、波状の縁が残ります。
同じ免疫反応は、眼窩や皮膚のTSH受容体を発現する線維芽細胞を標的にします。
眼周の腫れ(眼窩周囲浮腫)、眼球突出(眼球)、すねの肥厚斑(前脛部粘液浮腫)を引き起こします。
血液中の過剰なT4とT3は代謝率を上げ、熱の産生と心拍数を増加させます。
View the full transcript and gain access to JoVE Core videos
Q1: How do thyroid-stimulating immunoglobulins cause Graves' disease?
In Graves' disease, thyroid-stimulating immunoglobulins (TSI) are autoantibodies produced when immune tolerance fails. These antibodies bind to TSH receptors on thyroid follicular cells and mimic thyroid-stimulating hormone, continuously overstimulating the receptors. This bypasses normal feedback control, causing excessive production and release of T4 and T3 without regulation.
Q2: What microscopic changes occur in thyroid follicular cells during Graves' disease?
Thyroid follicular cells become tall and columnar, increase in number, and crowd together. Vascularity increases significantly throughout the gland. Colloid stores are rapidly depleted due to excessive hormone utilization, leaving characteristic wavy or scalloped edges on the follicles.
Q3: Why does Graves' disease cause eye protrusion and orbital swelling?
The same autoimmune response targeting thyroid cells also affects fibroblasts expressing TSH receptors in the orbit. Glycosaminoglycan deposition in orbital fibroblasts causes edema and tissue swelling, leading to periorbital edema and exophthalmos, or eye protrusion. This extrathyroidal manifestation occurs independently of thyroid hormone levels.
Q4: What is pretibial myxedema and how does it develop in Graves' disease?
Pretibial myxedema is thickened, swollen skin patches appearing on the shins. It develops when the autoimmune response targets TSH receptors on skin fibroblasts, particularly in the pretibial region. Glycosaminoglycan accumulation in these fibroblasts causes localized edema and tissue thickening characteristic of this condition.
Q5: How do elevated thyroid hormones affect metabolic rate and heart function in Graves' disease?
Excess T4 and T3 in the blood increase basal metabolic rate and heat production. Elevated thyroid hormones also increase sensitivity to catecholamines, raising heart rate and cardiac output. This hypermetabolic state produces tachycardia, palpitations, heat intolerance, and increased sweating as patients struggle to dissipate excess metabolic heat.
Q6: Why does negative feedback control fail to suppress thyroid hormone production in Graves' disease?
Although elevated T3 and T4 normally suppress pituitary TSH through negative feedback, this regulatory mechanism fails in Graves' disease. Antibody-mediated stimulation of TSH receptors persists independently of TSH levels, continuously driving thyroid hormone synthesis. The immune attack bypasses the normal hypothalamic-pituitary-thyroid axis control.
Q7: What systemic symptoms result from the hypermetabolic state in Graves' disease?
The hypermetabolic state produces weight loss despite increased appetite, fine tremors, anxiety, and hyperactivity. Patients experience tachycardia, palpitations, muscle weakness, and heat intolerance with excessive sweating. In severe cases, arrhythmias or thyroid storm may develop, representing life-threatening complications of uncontrolled hyperthyroidism.